GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (STU:I7G) » Definitions » Other Current Payables

Ipsen (STU:I7G) Other Current Payables : €0 Mil (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Ipsen Other Current Payables?

Ipsen's Other Current Payables for the quarter that ended in Dec. 2023 was €0 Mil.

Ipsen's quarterly Other Current Payables increased from Dec. 2022 (€0 Mil) to Jun. 2023 (€39 Mil) but then declined from Jun. 2023 (€39 Mil) to Dec. 2023 (€0 Mil).


Ipsen Other Current Payables Historical Data

The historical data trend for Ipsen's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Other Current Payables Chart

Ipsen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ipsen Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 39.00 -

Ipsen Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Ipsen Other Current Payables Related Terms

Thank you for viewing the detailed overview of Ipsen's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipsen (STU:I7G) Business Description

Traded in Other Exchanges
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.

Ipsen (STU:I7G) Headlines

No Headlines